Andersons pediatric cardiology 1799
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.96 KB, 3 trang )
transplantrecipients:functionalsignificance.
PflugersArch.2002;443:698–706.
92.PastoreE,TurchettaA,AttiasL,etal.
Cardiorespiratoryfunctionalassessmentafter
pediatrichearttransplantation.Pediatr
Transplant.2001;5:425–429.
93.PahlE,SundararaghavanS,StrasburgerJF.
Impairedexerciseparametersinpediatricheart
transplantrecipients:comparisonofbiatrialand
bicavaltechniques.PediatrTransplant.
2000;4:268–272.
94.DavisJA,McBrideMG,ChrisantMRK,etal.
Longitudinalassessmentofcardiovascular
exerciseperformanceafterpediatricheart
transplantation.JHeartLungTransplant.
2006;25:626–633.
95.DipchandAI,ManlhiotC,RussellJ,etal.
Exercisecapacityimproveswithtimein
pediatrichearttransplantrecipients.JHeart
LungTransplant.2009;28:585–590.
96.GreenM,MichaelsMG.Infectionsinpediatric
solidorgantransplantrecipients.JPediatric
InfectDisSoc.2012;1:144–151.
97.RostadCA,WehrheimK,KirklinJK,etal.
Bacterialinfectionsafterpediatricheart
transplantation:epidemiology,riskfactorsand
outcomes.JHeartLungTransplant.2017;
10.1016/j.healun.2017.05.009[May11.pii:
S1053-2498(17)31790-4].
98.KowalskyS,ArnonR,PosadaR.Preventionof
cytomegalovirusfollowingsolidorgan
transplantation:aliteraturereview.Pediatr
Transplant.2013;17:499–509.
99.NgB,DipchandA,NaftelD,etal.Outcomesof
pneumocystisjirovecipneumoniainfectionsin
pediatrichearttransplantrecipients.Pediatr
Transplant.2011;15:844–848.
100.ThomasB,FlettJG,ShyamR,etal.Chronic
respiratorycomplicationsinpaediatricheart
transplantrecipients.JHeartLungTransplant.
2007;26:236–240.
101.CroceE,HatzC,JonkerEF,etal.Safetyoflive
vaccinationsonimmunosuppressivetherapyin
patientswithimmune-mediatedinflammatory
diseases,solidorgantransplantationorafter
bone-marrowtransplantation-Asystematic
reviewofrandomizedtrials,observational
studiesandcasereports.Vaccine.2017;35:1216–
1226.
102.TangL,DuW,LEcuyerTJ.Perioperativerenal
failureinpediatrichearttransplantrecipients:
outcomeandriskfactors.PediatrTransplant.
2011;15:430–436.
103.JainA,MattooTK.Laterenaldysfunctionafter
pediatrichearttransplantation.ProgPediatr
Cardiol.2016;41:41–45.
104.SierraCM,TanR,EguchiJ,etal.Calcineurin
inhibitor-andcorticosteroid-free
immunosuppressioninpediatrichearttransplant
patients.PediatrTransplant.2017;21(1);
10.1111/petr.12808.
105.SchubertS,Abdul-KhaliqH,LehmkuhlHB,et
al.Diagnosisandtreatmentofposttransplantationlymphoproliferativedisorderin
pediatrichearttransplantpatients.Pediatr
Transplant.2009;13:54–62.
106.RossM,KouretasP,GambergP,etal.Ten-and
20-yearsurvivorsofpediatricorthotopicheart
transplantation.JHeartLungTransplant.
2006;25:261–270.
107.ChinnockR,WebberSA,DipchandAI,etal.A
16-yearmulti-institutionalstudyoftheroleof
ageandEBVstatusonPTLDincidenceamong
pediatrichearttransplantrecipients.AmJ
Transplant.2012;12(11):3061–3068.
108.SchechterT,GassasA,WeitzmanS,etal.
Hematopoieticstem-celltransplantation
followingsolid-organtransplantationinchildren.
BoneMarrowTransplant.2011;46(10):1321–
1325.
109.BannisterL1,ManlhiotC,Pollock-BarZivS,et
